Immunohistochemistry and Microscopy

Histochemical Society
Cosponsored by The Histochemical Society

The mission of the Immunohistochemistry & Microscopy Scientific Interest Group (IHCM SIG) is to promote high quality immunohistochemistry and the development of new assays that take advantage of new reagents and techniques, state-of-the-art imaging systems and image analysis. Immunohistochemistry is one of the most widely used techniques in biomedical research, providing spatial and functional information about target molecules in cells, tissues and organs. Immunohistochemistry is constantly evolving in methodology and applications, both within the clinical and research spaces, and one of the challenges faced by researchers is the application of adequately validated assays.

The objectives of the IHCM SIG are to:

  1. Provide a forum for discussion concerning the application of immunohistochemistry in biomedical science.
  2. Disseminate guidance to the community on development of specific and robust chromagen- and fluorescent-based immunohistochemical assays.
  3. Promote new approaches and applications of immunohistochemistry.
  4. Provide a venue of exchange to address challenges researchers encounter in immunohistochemistry.
  5. Provide a forum for discussion on advances in microscopy, imaging, image analysis and quantitative microscopy.

The IHCM SIG is as a partnership between the Histochemical Society and the American Society for Investigative Pathology. Members of the Histochemical Society are invited to attend all IHCM SIG events. To fully participate and be part of the SIG listserv, Histochemical Society members are invited to become an ASIP member.


ASIP Members are invited to participate in the Immunohistochemistry and Microscopy SIG Listserv. Please email to have your name and email address added to the listserv.

To send a message to the Immunohistochemistry and Microscopy SIG Listserv, send your email to Please note that you must be a member of this listserv in order to send and receive messages.

Please direct all questions to: Lisa McFadden (240) 283-9712.


Stephen Hewitt

Stephen M. Hewitt, MD, PhD
National Cancer Institute
National Institutes of Health


Charles Frevert

Charles W. Frevert, DVM, ScD
University of Washington School of Medicine